Severe Hypoglycemia and Cardiovascular or All-Cause Mortality in Patients with Type 2 Diabetes
- PMID: 27098504
- PMCID: PMC4929224
- DOI: 10.4093/dmj.2016.40.3.202
Severe Hypoglycemia and Cardiovascular or All-Cause Mortality in Patients with Type 2 Diabetes
Abstract
Background: We investigated the association between severe hypoglycemia (SH) and the risk of cardiovascular (CV) or all-cause mortality in patients with type 2 diabetes.
Methods: The study included 1,260 patients aged 25 to 75 years with type 2 diabetes from the Vincent Type 2 Diabetes Resgistry (VDR), who consecutively enrolled (n=1,260) from January 2000 to December 2010 and were followed up until May 2015 with a median follow-up time of 10.4 years. Primary outcomes were death from any cause or CV death. We investigated the association between the CV or all-cause mortality and various covariates using Cox proportional hazards regression analysis.
Results: Among the 906 participants (71.9%) who completed follow-up, 85 patients (9.4%) had at least one episode of SH, and 86 patients (9.5%) died (9.1 per 1,000 patient-years). Patients who had died were older, had a longer duration of diabetes and hypertension, received more insulin, and had more diabetic microvascular complications at baseline, as compared with surviving patients. The experience of SH was significantly associated with an increased risk of all-cause mortality (hazard ratio [HR], 2.64; 95% confidence interval [CI], 1.39 to 5.02; P=0.003) and CV mortality (HR, 6.34; 95% CI, 2.02 to 19.87; P=0.002) after adjusting for sex, age, diabetic duration, hypertension, mean glycosylated hemoglobin levels, diabetic nephropathy, lipid profiles, and insulin use.
Conclusion: We found a strong association between SH and increased risk of all-cause and CV mortality in patients with type 2 diabetes.
Keywords: Cardiovascular diseases; Diabetes mellitus, type 2; Mortality; Severe hypoglycemia.
Conflict of interest statement
Figures
Similar articles
-
Cardiovascular Disease Predicts Severe Hypoglycemia in Patients with Type 2 Diabetes.Diabetes Metab J. 2015 Dec;39(6):498-506. doi: 10.4093/dmj.2015.39.6.498. Epub 2015 Jul 8. Diabetes Metab J. 2015. PMID: 26370882 Free PMC article.
-
Excess Mortality among Persons with Type 2 Diabetes.N Engl J Med. 2015 Oct 29;373(18):1720-32. doi: 10.1056/NEJMoa1504347. N Engl J Med. 2015. PMID: 26510021
-
Association between 7 years of intensive treatment of type 1 diabetes and long-term mortality.JAMA. 2015 Jan 6;313(1):45-53. doi: 10.1001/jama.2014.16107. JAMA. 2015. PMID: 25562265 Free PMC article. Clinical Trial.
-
Anaemia, independent of chronic kidney disease, predicts all-cause and cardiovascular mortality in type 2 diabetic patients.Atherosclerosis. 2010 Jun;210(2):575-80. doi: 10.1016/j.atherosclerosis.2009.12.008. Epub 2009 Dec 11. Atherosclerosis. 2010. PMID: 20031129
-
Effects of glucose-lowering and multifactorial interventions on cardiovascular and mortality outcomes: a meta-analysis of randomized control trials.Diabet Med. 2016 Mar;33(3):280-9. doi: 10.1111/dme.12885. Epub 2015 Sep 8. Diabet Med. 2016. PMID: 26282461 Review.
Cited by
-
Predictors of Diabetes Self-Care Practice Among Patients with Type 2 Diabetes in Public Hospitals in Northeastern Ethiopia: A Facility-Based Cross-Sectional Study.Diabetes Metab Syndr Obes. 2020 Sep 10;13:3137-3147. doi: 10.2147/DMSO.S273682. eCollection 2020. Diabetes Metab Syndr Obes. 2020. PMID: 32982346 Free PMC article.
-
Hypoglycemia: Culprit or Bystander?Diabetes Metab J. 2016 Jun;40(3):190-1. doi: 10.4093/dmj.2016.40.3.190. Diabetes Metab J. 2016. PMID: 27352252 Free PMC article. No abstract available.
-
The association between stress-induced hyperglycemia ratio and cardiovascular events as well as all-cause mortality in patients with chronic kidney disease and diabetic nephropathy.Cardiovasc Diabetol. 2025 Feb 6;24(1):55. doi: 10.1186/s12933-025-02610-1. Cardiovasc Diabetol. 2025. PMID: 39915833 Free PMC article.
-
Epidemiology and outcomes from severe hypoglycemia in Kuwait: a prospective cohort study.BMC Emerg Med. 2021 May 29;21(1):65. doi: 10.1186/s12873-021-00457-9. BMC Emerg Med. 2021. PMID: 34051726 Free PMC article.
-
Cardiovascular safety and lower severe hypoglycaemia of insulin degludec versus insulin glargine U100 in patients with type 2 diabetes aged 65 years or older: Results from DEVOTE (DEVOTE 7).Diabetes Obes Metab. 2019 Jul;21(7):1625-1633. doi: 10.1111/dom.13699. Epub 2019 Apr 15. Diabetes Obes Metab. 2019. PMID: 30850995 Free PMC article. Clinical Trial.
References
-
- Cryer PE. Hypoglycaemia: the limiting factor in the glycaemic management of type I and type II diabetes. Diabetologia. 2002;45:937–948. - PubMed
-
- Action to Control Cardiovascular Risk in Diabetes Study Group. Gerstein HC, Miller ME, Byington RP, Goff DC, Jr, Bigger JT, Buse JB, Cushman WC, Genuth S, Ismail-Beigi F, Grimm RH, Jr, Probstfield JL, Simons-Morton DG, Friedewald WT. Effects of intensive glucose lowering in type 2 diabetes. N Engl J Med. 2008;358:2545–2559. - PMC - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources